Pembrolizumab and involved site radiation therapy alone as an alternative to transplant in patients with localized failure following chemotherapy for Hodgkin Lymphoma: A prospective multicenter phase II study Meeting Abstract

  

Authors:	Dreyfuss, A.; Ganesan, N.; Alencar, A. J.; Boardman, A. P.; Caron, P.; Chang, T.; Davey, T.; David, K. A.; Dogan, A.; Epstein-Peterson, Z. D.; Falchi, L.; Fregonese, B.; Ghione, P.; Hamlin, P. A.; Horwitz, S.; Imber, B. S.; Intlekofer, A. M.; Isrow, D.; Joffe, E.; Johnson, W. T.; Kumar, A.; Lariviere, M.; Lue, J. K.; Luttwak, E.; McNicholas, M.; Moore, Z.; Munayirji, B.; Noy, A.; Owens, C.; Palomba, M. L.; Patel, J.; Plastaras, J. P.; Santarosa, A. M.; Schoder, H.; Shah, G. L.; Steiner, R. E.; Stuver, R.; Svoboda, J.; Torka, P.; Vardhana, S. A.; Zelenetz, A. D.; Salles, G.; Yahalom, J.; Moskowitz, C. H.; Moskowitz, A.
Abstract Title:	Pembrolizumab and involved site radiation therapy alone as an alternative to transplant in patients with localized failure following chemotherapy for Hodgkin Lymphoma: A prospective multicenter phase II study
Meeting Title:	66th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	144
Issue:	Suppl. 1
Meeting Dates:	2024 Dec 7-10
Meeting Location:	San Diego, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2024-11-05
Start Page:	4434
Language:	English
ACCESSION:	WOS:001410587900019
DOI:	10.1182/blood-2024-210689
PROVIDER:	wos
Notes:	Meeting Abstract -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/226994